Selection of new markers for animal by-products characterization by classical microscopy

The aim of this study was to identify possible markers to distinguish differences between land animals by using the microscopic method in association with computer image analysis. For this purpose bone fragments from poultry and mammals were obtained and analysed by microscopic method. Through a digital camera and an image analysis software 85 bone lacunae images have been processed and elaborated in order to obtain for each lacuna a monochrome mask on which several measurements were performed. Data were analysed by ANOVA and LDA. Results obtained in the present study indicated that of 32 descriptors processed by image analysis software, only 12 were significantly (P<0.001) different between mammalian and poultry. However, when morphometric measurements were analysed by LDA, 86% of lacunae were correctly classified into the animal class of origin (i.e. mammalian as mammalian and poultry as poultry). By contrast 14% of lacunae were incorrectly classified. In conclusion, data here presented indicate that some of descriptors used by image analysis appears promising not only for a reliable distinction between the different origins of animal meal at the level of vertebrate classes, but also for further characterisation and identification of processed animal proteins in animal feeds

Feed particle size evaluation: conventional approach versus digital holography based image analysis

The aim of this study was to evaluate the application of image analysis approach based on digital holography in defining particle size in comparison with the sieve shaker method (sieving method) as reference method. For this purpose ground corn meal was analyzed by a sieve shaker Retsch VS 1000 and by image analysis approach based on digital holography. Particle size from digital holography were compared with results obtained by screen (sieving) analysis for each of size classes by a cumulative distribution plot. Comparison between particle size values obtained by sieving method and image analysis indicated that values were comparable in term of particle size information, introducing a potential application for digital holography and image analysis in feed industry

Small for Gestational Age Preterm Neonates Exhibit Defective GH/IGF1 Signaling Pathway

Objective: To investigate the impact of fetal growth restriction (FGR) on hormonal regulation of post-natal growth and glucose metabolism [via insulin and growth hormone (GH)/Insulin-like Growth factor 1 (IGF1) axis pathways] in small for gestational age (SGA) neonates. Methods: We conducted a monocentric observational prospective comparative study on 73 singleton babies born with a weight inferior to 2,000 g. We analyzed auxological (weight, height and head circumference), and hormonal (GH, IGF1, and insulin plasma concentrations) data comparing SGA and appropriate for gestational age (AGA) neonates, between day 1 and 60. Results: One third (23/73) of the neonates were SGA. Twenty-five percent (18/73) required insulin for idiopathic hyperglycemia of prematurity and were smaller in weight and head circumference at discharge. In the SGA group compared with the AGA group, GH plasma concentrations were higher at day 3 (70.1 vs. 38.0 mIU/L) and IGF1 plasma concentrations were higher at day 10 (29.0 vs. 18.7 ng/ml). Conclusions: SGA neonates displayed resistance to GH and IGF1, concomitant to insulin resistance. This could partially explain the initial defective catch-up growth and, later in life, the higher prevalence of metabolic syndrome in this population

sj-pdf-1-msj-10.1177_13524585211003291 – Supplemental material for Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry

Supplemental material, sj-pdf-1-msj-10.1177_13524585211003291 for Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry by Asta Theodorsdottir, Birgit Debrabant, Melinda Magyari, Matthias Kant, Peter V Rasmussen, Carl-Fredrik Malmberg, Iver Norberg, Victoria Hansen, Danny Bech, Mathias F Schmidt, Karen Schreiber, Jette L Frederiksen, Finn Sellebjerg and Zsolt Illes in Multiple Sclerosis Journa

Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry

Objective:To investigate clinical outcomes in a real-world setting in the complete population-based cohort of alemtuzumab-treated MS patients in Denmark.Methods:Data were retrieved from The Danish Multiple Sclerosis Registry between 2009 and 2019. Demographic and disease-specific patient parameters related to treatment history, efficacy, and safety outcomes were assessed at baseline and during follow-up visits.Results:A total of 209 patients (78% female) started treatment with alemtuzumab during the study period with 3.1 ± 1.4 years follow-up. After 2 years, 75% of patients were relapse-free compared to 48% the year before alemtuzumab (p p p = 0.001).Conclusion:In a country with primarily escalation strategy, relapse rate reduction was maintained for 5 years, and EDSS stabilized/improved in majority of patients. Higher relapse rate 1 year before alemtuzumab increased the odds for additional courses. Novel serious AEs were not observed